Abbott hits pulsed field ablation milestone, Medtronic has positive spinal cord stimulation data

Fast Five Medtech News Podcast

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, January 19, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Onward began a study of its neurostimulation technology for addressing post-spinal cord injury hemodynamic instability. Fast Five hosts Sean Whooley and Danielle Kirsh look at what this study aims to accomplish and discuss how Onward applies its technology in a variety of ways. The FDA approved expanded labeling for the Abbott Proclaim neurostimulation system, allowing those implanted with the device to receive full-body MRI scans. The hosts look into the importance of MRI compatibility and how the Proclaim system works. Orthofix partnered with MRIguidance, combining surgical navigation technology with innovative software. Find out what this partnership entails and how the companies feel about their latest development. Medtronic reported positive data for multiple spinal cord stimulation technologies. Hear about some of the key results from the medtech giant's studies presented at the North American Neuromodulation Society (NANS) annual meeting in Las Vegas. Abbott announced the first procedures completed with its Volt pulsed field ablation system. Whooley and Kirsh take a look at the latest entry into the crowded PFA space and examine what could potentially set Abbott's new technology apart.